|Day Low/High||127.27 / 129.01|
|52 Wk Low/High||92.98 / 137.54|
CELG looks like it has a promising future, according to the charts.
Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced that IDHIFA ® (enasidenib) was granted approval from the U.
Multiples have become quite rich and dysfunction in Washington could end up biting the markets.
Celgene Corporation (NASDAQ:CELG) plans to present at an upcoming investor conference where Celgene management will provide an overview of the Company.
The Nasdaq tumbles and the S&P 500 slides. The Dow rises slightly.
Celgene Corporation (NASDAQ:CELG) reported net product sales of $3,256 million for the second quarter of 2017, a 19 percent increase from the same period in 2016.
U.S. stock futures point higher after Facebook shares jump.
Celgene Corporation (NASDAQ:CELG) today announced that it has reached a civil settlement with Relator Brown, the Department of Justice, 28 States, the District of Columbia, and the City of Chicago to resolve the previously...
Celgene had been accused of marketing off-label uses for two of its cancer treatments.
Stock prices are either unfairly dragged down by competitors' earnings news or by Amazon's spread into more businesses, Cramer said.
Wall Street's first glimpse at the second quarter.
Here's what to focus on from these stocks in July.
The FDA has placed a clinical hold on three combination studies of Merck's Keytruda in multiple myeloma.
Celgene acquired the rights to BeiGene's PD-1 checkpoint inhibitor, propelling the biotech giant forward in immuno-oncology research.
BeiGene and Impax Laboratories were among the biotech movers in premarket trading on July 6.
Celgene Corporation (NASDAQ:CELG) and BeiGene, Ltd. (NASDAQ:BGNE) entered into a strategic collaboration to develop and commercialize BeiGene's investigational anti-programmed cell death protein 1 (PD-1) inhibitor,...
Leerink analysts see Celgene continuing in an upward trend as its new multiple sclerosis drug ozanimod differentiates itself from a competitive field.
Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio webcast on Thursday, July 27, 2017 at 9 a.